This item requires a subscription to Diabetes Care.
Full Text
Original Research - Emerging Treatments and Technologies:
Markus Walter,
Areti Philotheou,
François Bonnici,
Anette-G. Ziegler,
Roland Jimenez,
and on behalf of the NBI-6024 Study Group
No Effect of the Altered Peptide Ligand NBI-6024 on β-Cell Residual Function and Insulin Needs in New-Onset Type 1 Diabetes
Diabetes Care November 2009 32:2036-2040; published ahead of print August 18, 2009, doi:10.2337/dc09-0449